Alan F. Denenberg

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Seattle Genetics, Inc. of 13,269,230 shares…

Davis Polk advised Ultra Clean Holdings, Inc. on its SEC-registered follow-on public offering of 4,761,905 shares of common stock for an aggregate price to the public of approximately $100…

Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Varian Medical Systems, Inc. in connection with its approximately A$1.6 billion acquisition of Sirtex Medical…

Davis Polk advised the joint book-running managers in connection with a $115 million SEC-registered offering of 5,897,435 shares of common stock of Five Prime Therapeutics, Inc. The…

Davis Polk advised Silver Lake on its $250 million investment in WPEngine, Inc. Silver Lake is a global leader in technology investing, with about $39 billion in combined assets under…

Davis Polk advised the dealer manager in connection with the registered offer by Amazon.com, Inc. to exchange $1 billion aggregate principal amount of 5.200% senior notes of Whole…

Davis Polk advised Equinix, Inc. on its SEC-registered offering of €1 billion aggregate principal amount of 2.875% senior notes due 2026. Equinix, Inc. intends to use the net proceeds of…

Davis Polk advised the underwriters in connection with an initial public offering of 15,972,221 shares of common stock of Denali Therapeutics Inc., including shares sold pursuant to the…

Davis Polk advised the dealer managers in connection with the offers by Intel Corporation to exchange any and all of its outstanding $1.5 billion 4.80% senior notes due 2041, $925…

Davis Polk advised the underwriter in connection with a $344 million public offering of GoDaddy Inc. Class A common stock. Certain existing stockholders sold 7,227,622 shares and…